|
Volumn 4, Issue 2, 2003, Pages 209-215
|
deCODE genetics, Inc
|
Author keywords
Complex disease; Diagnostic test; Disease specific drugs; Genealogical approach; Human genetics; Pharmacogenomics; Target validation
|
Indexed keywords
ANTIHYPERTENSIVE AGENT;
ANTIINFLAMMATORY AGENT;
ANTILIPEMIC AGENT;
ANTIMIGRAINE AGENT;
DNA;
GLUCOCORTICOID;
N METHYL DEXTRO ASPARTIC ACID RECEPTOR;
NEU DIFFERENTIATION FACTOR;
NEW DRUG;
PHENCYCLIDINE;
SEROTONIN UPTAKE INHIBITOR;
ACCURACY;
ARTICLE;
DEPRESSION;
DIAGNOSTIC PROCEDURE;
DISEASE PREDISPOSITION;
DNA MICROARRAY;
DRUG MONITORING;
DRUG RESPONSE;
DRUG TARGETING;
GENE EXPRESSION PROFILING;
GENE ISOLATION;
GENE LINKAGE DISEQUILIBRIUM;
GENE MAPPING;
GENEALOGY;
GENETIC DATABASE;
GENETIC REGULATION;
GENOTYPE;
HUMAN;
HYPERLIPIDEMIA;
HYPERTENSION;
ICELAND;
LINKAGE ANALYSIS;
METHODOLOGY;
MIGRAINE;
PHARMACOGENOMICS;
PHENOTYPE;
POPULATION GENETICS;
POPULATION RESEARCH;
PREDICTION;
RHEUMATOID ARTHRITIS;
CHROMOSOME MAPPING;
DATABASES, FACTUAL;
GENETICS, POPULATION;
GENOTYPE;
HUMANS;
ICELAND;
PEDIGREE;
PHARMACEUTICAL PREPARATIONS;
PHARMACOGENETICS;
PHENOTYPE;
PRIVATE SECTOR;
|
EID: 0037340869
PISSN: 14622416
EISSN: None
Source Type: Journal
DOI: 10.1517/phgs.4.2.209.22627 Document Type: Article |
Times cited : (56)
|
References (7)
|